Report shares new details about death possibly linked to experimental Alzheimer's drug
The death of a participant in a clinical trial of an antibody treatment for Alzheimer's disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug,
Thursday, January 5, 2023 at 12:59 am